IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

New Treatment for MS

Clinical Trials, Inc. Information at arkansasclinicaltrials.com
Wed Oct 22 09:56:12 EST 2003


Every week 200 people will be diagnosed with this devastating disease. Most
of them will be women, and most will be in the prime of their lives-between
ages 30 and 40 years.

Although, a variety of medications are available to treat the symptoms of
this disease, there is currently no cure for MS. The medical community is
constantly searching for new and better treatments and a number of
investigational drugs are being tested as possible treatments for MS.

One of these drugs is called CAMPATH®, which has shown potential in an
investigator-sponsored trial in its ability to slow the progression of MS.
If this investigational drug is eventually approved as a treatment for MS,
it would be a major advancement in the treatment of this disease.

If you or someone you know has been diagnosed with MS in the last three
years, you may be eligible to participate in a clinical trial. Qualified
participants will receive study medication, study-related physical and
laboratory evaluations at no cost. To learn more, please call 501-227-6179,
or visit our website: www.arkansasclinicaltrials.com

More information about the Neur-sci mailing list

Send comments to us at biosci-help [At] net.bio.net